News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
DakoCytomation A/S Release: BRCA-1 Gene Hinders Malignant Cell Progression
October 19, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
BRCA-1 is a breast cancer susceptibility gene that is mutated in the majority of hereditable breast cancers. Furthermore, recent studies have determined that approximately 3% of all breast cancers have germline mutations in the BRCA-1 gene.
Twitter
LinkedIn
Facebook
Email
Print
Europe
MORE ON THIS TOPIC
Insights
Italian biotech gains momentum as VC funding, tech transfer environment improve
August 17, 2026
·
3 min read
·
Jennifer C. Smith-Parker
Regulatory
Pressure piles on Amgen after EU pulls Tavneos, flags ‘serious breaches’ in pivotal study
August 14, 2026
·
2 min read
·
Tristan Manalac
Insights
The Italian inflection point: Clinical strength, culture and capital
August 13, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Insights
Austria’s new growth fund could further bolster its dynamic biotech innovation economy
August 11, 2026
·
5 min read
·
Jennifer C. Smith-Parker